By Josh Beckerman Evoke Pharma shares surged after the company received a notice of allowance for a U.S. patent application for Gimoti extending Orange Book listings to 2036.

Palvella Therapeutics received a patent for QTORIN™ rapamycin, enhancing its exclusivity strategy in treating rare skin diseases.

Merck, as it prepares a new version of its cancer blockbuster Keytruda, gets a boost in its patent dispute with Halozyme Therapeutics.

In China, the term of an invention patent is 20 years from the application date. The Patent Law, which took effect in 2021, introduced provisions for patent term compensation. There are two types of ...

Ideally, the patent portfolio should protect the company’s foundational technology –especially its market differentiators.

Nokia has finalized a patent agreement with Amazon.com, granting access to its video technologies for streaming services. This deal resolves all legal disputes between the two companies while ...

A Ford patent suggests the automaker could put a manual shifter in electric vehicles as a nostalgic touch for old car lovers.

Vaxxas, a clinical-stage biotechnology company, today announced it has secured a new patent from the United States patent office covering proprietary manufac ...

GLP-1 receptor agonists (GLP-1RAs) were initially approved for diabetes treatment (e.g., Ozempic®) but have revolutionized weight management (e.g., Wegovy®) and are now being explored for ...

Jean Marsden died on March 7 in a head-on collision with another Holland Patent School District bus.

Halozyme is prepared to sue Merck for patent infringement if the New Jersey pharma doesn't agree to a licensing deal around subcutnaeous Keytruda.